Global NGS Tumor Gene Analysis Software Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global NGS Tumor Gene Analysis Software market size was valued at USD 1552.7 million in 2022 and is forecast to a readjusted size of USD 4590 million by 2029 with a CAGR of 16.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.
This report is a detailed and comprehensive analysis for global NGS Tumor Gene Analysis Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global NGS Tumor Gene Analysis Software market size and forecasts, in consumption value ($ Million), 2018-2029
Global NGS Tumor Gene Analysis Software market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global NGS Tumor Gene Analysis Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global NGS Tumor Gene Analysis Software market shares of main players, in revenue ($ Million), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for NGS Tumor Gene Analysis Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global NGS Tumor Gene Analysis Software market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Illumina, Thermo Fisher Scientific, BGI Group and Novogene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
NGS Tumor Gene Analysis Software market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe NGS Tumor Gene Analysis Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of NGS Tumor Gene Analysis Software, with revenue, gross margin and global market share of NGS Tumor Gene Analysis Software from 2018 to 2023.
Chapter 3, the NGS Tumor Gene Analysis Software competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and NGS Tumor Gene Analysis Software market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of NGS Tumor Gene Analysis Software.
Chapter 13, to describe NGS Tumor Gene Analysis Software research findings and conclusion.
NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.
This report is a detailed and comprehensive analysis for global NGS Tumor Gene Analysis Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global NGS Tumor Gene Analysis Software market size and forecasts, in consumption value ($ Million), 2018-2029
Global NGS Tumor Gene Analysis Software market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global NGS Tumor Gene Analysis Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global NGS Tumor Gene Analysis Software market shares of main players, in revenue ($ Million), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for NGS Tumor Gene Analysis Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global NGS Tumor Gene Analysis Software market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Illumina, Thermo Fisher Scientific, BGI Group and Novogene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
NGS Tumor Gene Analysis Software market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Non-Small Cell Lung Cancer
- Human 6 Gene Mutations
- Human 12 Gene Mutations
- Other
- Hospitals and Health Systems
- Research Institute
- Other
- Roche
- Illumina
- Thermo Fisher Scientific
- BGI Group
- Novogene
- Geneseeq
- AmoyDx
- Burning Rock Medicine
- GTH.O
- Golden Helix, Inc
- Diatech Pharmacogenetics
- ViennaLab Diagnostics GmbH
- 3D Medicines
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe NGS Tumor Gene Analysis Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of NGS Tumor Gene Analysis Software, with revenue, gross margin and global market share of NGS Tumor Gene Analysis Software from 2018 to 2023.
Chapter 3, the NGS Tumor Gene Analysis Software competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and NGS Tumor Gene Analysis Software market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of NGS Tumor Gene Analysis Software.
Chapter 13, to describe NGS Tumor Gene Analysis Software research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of NGS Tumor Gene Analysis Software
1.2 Market Estimation Caveats and Base Year
1.3 Classification of NGS Tumor Gene Analysis Software by Type
1.3.1 Overview: Global NGS Tumor Gene Analysis Software Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Type in 2022
1.3.3 Non-Small Cell Lung Cancer
1.3.4 Human 6 Gene Mutations
1.3.5 Human 12 Gene Mutations
1.3.6 Other
1.4 Global NGS Tumor Gene Analysis Software Market by Application
1.4.1 Overview: Global NGS Tumor Gene Analysis Software Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Health Systems
1.4.3 Research Institute
1.4.4 Other
1.5 Global NGS Tumor Gene Analysis Software Market Size & Forecast
1.6 Global NGS Tumor Gene Analysis Software Market Size and Forecast by Region
1.6.1 Global NGS Tumor Gene Analysis Software Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global NGS Tumor Gene Analysis Software Market Size by Region, (2018-2029)
1.6.3 North America NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
1.6.4 Europe NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
1.6.6 South America NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche NGS Tumor Gene Analysis Software Product and Solutions
2.1.4 Roche NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina NGS Tumor Gene Analysis Software Product and Solutions
2.2.4 Illumina NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product and Solutions
2.3.4 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 BGI Group
2.4.1 BGI Group Details
2.4.2 BGI Group Major Business
2.4.3 BGI Group NGS Tumor Gene Analysis Software Product and Solutions
2.4.4 BGI Group NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BGI Group Recent Developments and Future Plans
2.5 Novogene
2.5.1 Novogene Details
2.5.2 Novogene Major Business
2.5.3 Novogene NGS Tumor Gene Analysis Software Product and Solutions
2.5.4 Novogene NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novogene Recent Developments and Future Plans
2.6 Geneseeq
2.6.1 Geneseeq Details
2.6.2 Geneseeq Major Business
2.6.3 Geneseeq NGS Tumor Gene Analysis Software Product and Solutions
2.6.4 Geneseeq NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Geneseeq Recent Developments and Future Plans
2.7 AmoyDx
2.7.1 AmoyDx Details
2.7.2 AmoyDx Major Business
2.7.3 AmoyDx NGS Tumor Gene Analysis Software Product and Solutions
2.7.4 AmoyDx NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AmoyDx Recent Developments and Future Plans
2.8 Burning Rock Medicine
2.8.1 Burning Rock Medicine Details
2.8.2 Burning Rock Medicine Major Business
2.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Product and Solutions
2.8.4 Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Burning Rock Medicine Recent Developments and Future Plans
2.9 GTH.O
2.9.1 GTH.O Details
2.9.2 GTH.O Major Business
2.9.3 GTH.O NGS Tumor Gene Analysis Software Product and Solutions
2.9.4 GTH.O NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GTH.O Recent Developments and Future Plans
2.10 Golden Helix, Inc
2.10.1 Golden Helix, Inc Details
2.10.2 Golden Helix, Inc Major Business
2.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Product and Solutions
2.10.4 Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Golden Helix, Inc Recent Developments and Future Plans
2.11 Diatech Pharmacogenetics
2.11.1 Diatech Pharmacogenetics Details
2.11.2 Diatech Pharmacogenetics Major Business
2.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product and Solutions
2.11.4 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Diatech Pharmacogenetics Recent Developments and Future Plans
2.12 ViennaLab Diagnostics GmbH
2.12.1 ViennaLab Diagnostics GmbH Details
2.12.2 ViennaLab Diagnostics GmbH Major Business
2.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product and Solutions
2.12.4 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 ViennaLab Diagnostics GmbH Recent Developments and Future Plans
2.13 3D Medicines
2.13.1 3D Medicines Details
2.13.2 3D Medicines Major Business
2.13.3 3D Medicines NGS Tumor Gene Analysis Software Product and Solutions
2.13.4 3D Medicines NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 3D Medicines Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global NGS Tumor Gene Analysis Software Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of NGS Tumor Gene Analysis Software by Company Revenue
3.2.2 Top 3 NGS Tumor Gene Analysis Software Players Market Share in 2022
3.2.3 Top 6 NGS Tumor Gene Analysis Software Players Market Share in 2022
3.3 NGS Tumor Gene Analysis Software Market: Overall Company Footprint Analysis
3.3.1 NGS Tumor Gene Analysis Software Market: Region Footprint
3.3.2 NGS Tumor Gene Analysis Software Market: Company Product Type Footprint
3.3.3 NGS Tumor Gene Analysis Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global NGS Tumor Gene Analysis Software Consumption Value and Market Share by Type (2018-2023)
4.2 Global NGS Tumor Gene Analysis Software Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2023)
5.2 Global NGS Tumor Gene Analysis Software Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
6.2 North America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
6.3 North America NGS Tumor Gene Analysis Software Market Size by Country
6.3.1 North America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
6.3.2 United States NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
6.3.3 Canada NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
6.3.4 Mexico NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
7.2 Europe NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
7.3 Europe NGS Tumor Gene Analysis Software Market Size by Country
7.3.1 Europe NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
7.3.2 Germany NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7.3.3 France NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7.3.4 United Kingdom NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7.3.5 Russia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7.3.6 Italy NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
8.2 Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
8.3 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region
8.3.1 Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2029)
8.3.2 China NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.3 Japan NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.4 South Korea NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.5 India NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.7 Australia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
9.2 South America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
9.3 South America NGS Tumor Gene Analysis Software Market Size by Country
9.3.1 South America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
9.3.2 Brazil NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
9.3.3 Argentina NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
10.2 Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
10.3 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country
10.3.1 Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
10.3.2 Turkey NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
10.3.4 UAE NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 NGS Tumor Gene Analysis Software Market Drivers
11.2 NGS Tumor Gene Analysis Software Market Restraints
11.3 NGS Tumor Gene Analysis Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 NGS Tumor Gene Analysis Software Industry Chain
12.2 NGS Tumor Gene Analysis Software Upstream Analysis
12.3 NGS Tumor Gene Analysis Software Midstream Analysis
12.4 NGS Tumor Gene Analysis Software Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of NGS Tumor Gene Analysis Software
1.2 Market Estimation Caveats and Base Year
1.3 Classification of NGS Tumor Gene Analysis Software by Type
1.3.1 Overview: Global NGS Tumor Gene Analysis Software Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Type in 2022
1.3.3 Non-Small Cell Lung Cancer
1.3.4 Human 6 Gene Mutations
1.3.5 Human 12 Gene Mutations
1.3.6 Other
1.4 Global NGS Tumor Gene Analysis Software Market by Application
1.4.1 Overview: Global NGS Tumor Gene Analysis Software Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Health Systems
1.4.3 Research Institute
1.4.4 Other
1.5 Global NGS Tumor Gene Analysis Software Market Size & Forecast
1.6 Global NGS Tumor Gene Analysis Software Market Size and Forecast by Region
1.6.1 Global NGS Tumor Gene Analysis Software Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global NGS Tumor Gene Analysis Software Market Size by Region, (2018-2029)
1.6.3 North America NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
1.6.4 Europe NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
1.6.6 South America NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche NGS Tumor Gene Analysis Software Product and Solutions
2.1.4 Roche NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina NGS Tumor Gene Analysis Software Product and Solutions
2.2.4 Illumina NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product and Solutions
2.3.4 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 BGI Group
2.4.1 BGI Group Details
2.4.2 BGI Group Major Business
2.4.3 BGI Group NGS Tumor Gene Analysis Software Product and Solutions
2.4.4 BGI Group NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BGI Group Recent Developments and Future Plans
2.5 Novogene
2.5.1 Novogene Details
2.5.2 Novogene Major Business
2.5.3 Novogene NGS Tumor Gene Analysis Software Product and Solutions
2.5.4 Novogene NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novogene Recent Developments and Future Plans
2.6 Geneseeq
2.6.1 Geneseeq Details
2.6.2 Geneseeq Major Business
2.6.3 Geneseeq NGS Tumor Gene Analysis Software Product and Solutions
2.6.4 Geneseeq NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Geneseeq Recent Developments and Future Plans
2.7 AmoyDx
2.7.1 AmoyDx Details
2.7.2 AmoyDx Major Business
2.7.3 AmoyDx NGS Tumor Gene Analysis Software Product and Solutions
2.7.4 AmoyDx NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AmoyDx Recent Developments and Future Plans
2.8 Burning Rock Medicine
2.8.1 Burning Rock Medicine Details
2.8.2 Burning Rock Medicine Major Business
2.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Product and Solutions
2.8.4 Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Burning Rock Medicine Recent Developments and Future Plans
2.9 GTH.O
2.9.1 GTH.O Details
2.9.2 GTH.O Major Business
2.9.3 GTH.O NGS Tumor Gene Analysis Software Product and Solutions
2.9.4 GTH.O NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GTH.O Recent Developments and Future Plans
2.10 Golden Helix, Inc
2.10.1 Golden Helix, Inc Details
2.10.2 Golden Helix, Inc Major Business
2.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Product and Solutions
2.10.4 Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Golden Helix, Inc Recent Developments and Future Plans
2.11 Diatech Pharmacogenetics
2.11.1 Diatech Pharmacogenetics Details
2.11.2 Diatech Pharmacogenetics Major Business
2.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product and Solutions
2.11.4 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Diatech Pharmacogenetics Recent Developments and Future Plans
2.12 ViennaLab Diagnostics GmbH
2.12.1 ViennaLab Diagnostics GmbH Details
2.12.2 ViennaLab Diagnostics GmbH Major Business
2.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product and Solutions
2.12.4 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 ViennaLab Diagnostics GmbH Recent Developments and Future Plans
2.13 3D Medicines
2.13.1 3D Medicines Details
2.13.2 3D Medicines Major Business
2.13.3 3D Medicines NGS Tumor Gene Analysis Software Product and Solutions
2.13.4 3D Medicines NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 3D Medicines Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global NGS Tumor Gene Analysis Software Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of NGS Tumor Gene Analysis Software by Company Revenue
3.2.2 Top 3 NGS Tumor Gene Analysis Software Players Market Share in 2022
3.2.3 Top 6 NGS Tumor Gene Analysis Software Players Market Share in 2022
3.3 NGS Tumor Gene Analysis Software Market: Overall Company Footprint Analysis
3.3.1 NGS Tumor Gene Analysis Software Market: Region Footprint
3.3.2 NGS Tumor Gene Analysis Software Market: Company Product Type Footprint
3.3.3 NGS Tumor Gene Analysis Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global NGS Tumor Gene Analysis Software Consumption Value and Market Share by Type (2018-2023)
4.2 Global NGS Tumor Gene Analysis Software Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2023)
5.2 Global NGS Tumor Gene Analysis Software Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
6.2 North America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
6.3 North America NGS Tumor Gene Analysis Software Market Size by Country
6.3.1 North America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
6.3.2 United States NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
6.3.3 Canada NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
6.3.4 Mexico NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
7.2 Europe NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
7.3 Europe NGS Tumor Gene Analysis Software Market Size by Country
7.3.1 Europe NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
7.3.2 Germany NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7.3.3 France NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7.3.4 United Kingdom NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7.3.5 Russia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
7.3.6 Italy NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
8.2 Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
8.3 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region
8.3.1 Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2029)
8.3.2 China NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.3 Japan NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.4 South Korea NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.5 India NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
8.3.7 Australia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
9.2 South America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
9.3 South America NGS Tumor Gene Analysis Software Market Size by Country
9.3.1 South America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
9.3.2 Brazil NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
9.3.3 Argentina NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
10.2 Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
10.3 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country
10.3.1 Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
10.3.2 Turkey NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
10.3.4 UAE NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 NGS Tumor Gene Analysis Software Market Drivers
11.2 NGS Tumor Gene Analysis Software Market Restraints
11.3 NGS Tumor Gene Analysis Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 NGS Tumor Gene Analysis Software Industry Chain
12.2 NGS Tumor Gene Analysis Software Upstream Analysis
12.3 NGS Tumor Gene Analysis Software Midstream Analysis
12.4 NGS Tumor Gene Analysis Software Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global NGS Tumor Gene Analysis Software Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global NGS Tumor Gene Analysis Software Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global NGS Tumor Gene Analysis Software Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche NGS Tumor Gene Analysis Software Product and Solutions
Table 8. Roche NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Illumina Company Information, Head Office, and Major Competitors
Table 11. Illumina Major Business
Table 12. Illumina NGS Tumor Gene Analysis Software Product and Solutions
Table 13. Illumina NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Illumina Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product and Solutions
Table 18. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. BGI Group Company Information, Head Office, and Major Competitors
Table 21. BGI Group Major Business
Table 22. BGI Group NGS Tumor Gene Analysis Software Product and Solutions
Table 23. BGI Group NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. BGI Group Recent Developments and Future Plans
Table 25. Novogene Company Information, Head Office, and Major Competitors
Table 26. Novogene Major Business
Table 27. Novogene NGS Tumor Gene Analysis Software Product and Solutions
Table 28. Novogene NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Novogene Recent Developments and Future Plans
Table 30. Geneseeq Company Information, Head Office, and Major Competitors
Table 31. Geneseeq Major Business
Table 32. Geneseeq NGS Tumor Gene Analysis Software Product and Solutions
Table 33. Geneseeq NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Geneseeq Recent Developments and Future Plans
Table 35. AmoyDx Company Information, Head Office, and Major Competitors
Table 36. AmoyDx Major Business
Table 37. AmoyDx NGS Tumor Gene Analysis Software Product and Solutions
Table 38. AmoyDx NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. AmoyDx Recent Developments and Future Plans
Table 40. Burning Rock Medicine Company Information, Head Office, and Major Competitors
Table 41. Burning Rock Medicine Major Business
Table 42. Burning Rock Medicine NGS Tumor Gene Analysis Software Product and Solutions
Table 43. Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Burning Rock Medicine Recent Developments and Future Plans
Table 45. GTH.O Company Information, Head Office, and Major Competitors
Table 46. GTH.O Major Business
Table 47. GTH.O NGS Tumor Gene Analysis Software Product and Solutions
Table 48. GTH.O NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. GTH.O Recent Developments and Future Plans
Table 50. Golden Helix, Inc Company Information, Head Office, and Major Competitors
Table 51. Golden Helix, Inc Major Business
Table 52. Golden Helix, Inc NGS Tumor Gene Analysis Software Product and Solutions
Table 53. Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Golden Helix, Inc Recent Developments and Future Plans
Table 55. Diatech Pharmacogenetics Company Information, Head Office, and Major Competitors
Table 56. Diatech Pharmacogenetics Major Business
Table 57. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product and Solutions
Table 58. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Diatech Pharmacogenetics Recent Developments and Future Plans
Table 60. ViennaLab Diagnostics GmbH Company Information, Head Office, and Major Competitors
Table 61. ViennaLab Diagnostics GmbH Major Business
Table 62. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product and Solutions
Table 63. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. ViennaLab Diagnostics GmbH Recent Developments and Future Plans
Table 65. 3D Medicines Company Information, Head Office, and Major Competitors
Table 66. 3D Medicines Major Business
Table 67. 3D Medicines NGS Tumor Gene Analysis Software Product and Solutions
Table 68. 3D Medicines NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. 3D Medicines Recent Developments and Future Plans
Table 70. Global NGS Tumor Gene Analysis Software Revenue (USD Million) by Players (2018-2023)
Table 71. Global NGS Tumor Gene Analysis Software Revenue Share by Players (2018-2023)
Table 72. Breakdown of NGS Tumor Gene Analysis Software by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in NGS Tumor Gene Analysis Software, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key NGS Tumor Gene Analysis Software Players
Table 75. NGS Tumor Gene Analysis Software Market: Company Product Type Footprint
Table 76. NGS Tumor Gene Analysis Software Market: Company Product Application Footprint
Table 77. NGS Tumor Gene Analysis Software New Market Entrants and Barriers to Market Entry
Table 78. NGS Tumor Gene Analysis Software Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global NGS Tumor Gene Analysis Software Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global NGS Tumor Gene Analysis Software Consumption Value Share by Type (2018-2023)
Table 81. Global NGS Tumor Gene Analysis Software Consumption Value Forecast by Type (2024-2029)
Table 82. Global NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023)
Table 83. Global NGS Tumor Gene Analysis Software Consumption Value Forecast by Application (2024-2029)
Table 84. North America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America NGS Tumor Gene Analysis Software Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe NGS Tumor Gene Analysis Software Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America NGS Tumor Gene Analysis Software Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Country (2024-2029) & (USD Million)
Table 114. NGS Tumor Gene Analysis Software Raw Material
Table 115. Key Suppliers of NGS Tumor Gene Analysis Software Raw Materials
Table 1. Global NGS Tumor Gene Analysis Software Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global NGS Tumor Gene Analysis Software Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global NGS Tumor Gene Analysis Software Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche NGS Tumor Gene Analysis Software Product and Solutions
Table 8. Roche NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Illumina Company Information, Head Office, and Major Competitors
Table 11. Illumina Major Business
Table 12. Illumina NGS Tumor Gene Analysis Software Product and Solutions
Table 13. Illumina NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Illumina Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product and Solutions
Table 18. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. BGI Group Company Information, Head Office, and Major Competitors
Table 21. BGI Group Major Business
Table 22. BGI Group NGS Tumor Gene Analysis Software Product and Solutions
Table 23. BGI Group NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. BGI Group Recent Developments and Future Plans
Table 25. Novogene Company Information, Head Office, and Major Competitors
Table 26. Novogene Major Business
Table 27. Novogene NGS Tumor Gene Analysis Software Product and Solutions
Table 28. Novogene NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Novogene Recent Developments and Future Plans
Table 30. Geneseeq Company Information, Head Office, and Major Competitors
Table 31. Geneseeq Major Business
Table 32. Geneseeq NGS Tumor Gene Analysis Software Product and Solutions
Table 33. Geneseeq NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Geneseeq Recent Developments and Future Plans
Table 35. AmoyDx Company Information, Head Office, and Major Competitors
Table 36. AmoyDx Major Business
Table 37. AmoyDx NGS Tumor Gene Analysis Software Product and Solutions
Table 38. AmoyDx NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. AmoyDx Recent Developments and Future Plans
Table 40. Burning Rock Medicine Company Information, Head Office, and Major Competitors
Table 41. Burning Rock Medicine Major Business
Table 42. Burning Rock Medicine NGS Tumor Gene Analysis Software Product and Solutions
Table 43. Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Burning Rock Medicine Recent Developments and Future Plans
Table 45. GTH.O Company Information, Head Office, and Major Competitors
Table 46. GTH.O Major Business
Table 47. GTH.O NGS Tumor Gene Analysis Software Product and Solutions
Table 48. GTH.O NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. GTH.O Recent Developments and Future Plans
Table 50. Golden Helix, Inc Company Information, Head Office, and Major Competitors
Table 51. Golden Helix, Inc Major Business
Table 52. Golden Helix, Inc NGS Tumor Gene Analysis Software Product and Solutions
Table 53. Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Golden Helix, Inc Recent Developments and Future Plans
Table 55. Diatech Pharmacogenetics Company Information, Head Office, and Major Competitors
Table 56. Diatech Pharmacogenetics Major Business
Table 57. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product and Solutions
Table 58. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Diatech Pharmacogenetics Recent Developments and Future Plans
Table 60. ViennaLab Diagnostics GmbH Company Information, Head Office, and Major Competitors
Table 61. ViennaLab Diagnostics GmbH Major Business
Table 62. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product and Solutions
Table 63. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. ViennaLab Diagnostics GmbH Recent Developments and Future Plans
Table 65. 3D Medicines Company Information, Head Office, and Major Competitors
Table 66. 3D Medicines Major Business
Table 67. 3D Medicines NGS Tumor Gene Analysis Software Product and Solutions
Table 68. 3D Medicines NGS Tumor Gene Analysis Software Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. 3D Medicines Recent Developments and Future Plans
Table 70. Global NGS Tumor Gene Analysis Software Revenue (USD Million) by Players (2018-2023)
Table 71. Global NGS Tumor Gene Analysis Software Revenue Share by Players (2018-2023)
Table 72. Breakdown of NGS Tumor Gene Analysis Software by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in NGS Tumor Gene Analysis Software, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key NGS Tumor Gene Analysis Software Players
Table 75. NGS Tumor Gene Analysis Software Market: Company Product Type Footprint
Table 76. NGS Tumor Gene Analysis Software Market: Company Product Application Footprint
Table 77. NGS Tumor Gene Analysis Software New Market Entrants and Barriers to Market Entry
Table 78. NGS Tumor Gene Analysis Software Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global NGS Tumor Gene Analysis Software Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global NGS Tumor Gene Analysis Software Consumption Value Share by Type (2018-2023)
Table 81. Global NGS Tumor Gene Analysis Software Consumption Value Forecast by Type (2024-2029)
Table 82. Global NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023)
Table 83. Global NGS Tumor Gene Analysis Software Consumption Value Forecast by Application (2024-2029)
Table 84. North America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America NGS Tumor Gene Analysis Software Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe NGS Tumor Gene Analysis Software Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America NGS Tumor Gene Analysis Software Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Country (2024-2029) & (USD Million)
Table 114. NGS Tumor Gene Analysis Software Raw Material
Table 115. Key Suppliers of NGS Tumor Gene Analysis Software Raw Materials
LIST OF FIGURES
Figure 1. NGS Tumor Gene Analysis Software Picture
Figure 2. Global NGS Tumor Gene Analysis Software Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Type in 2022
Figure 4. Non-Small Cell Lung Cancer
Figure 5. Human 6 Gene Mutations
Figure 6. Human 12 Gene Mutations
Figure 7. Other
Figure 8. Global NGS Tumor Gene Analysis Software Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. NGS Tumor Gene Analysis Software Consumption Value Market Share by Application in 2022
Figure 10. Hospitals and Health Systems Picture
Figure 11. Research Institute Picture
Figure 12. Other Picture
Figure 13. Global NGS Tumor Gene Analysis Software Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global NGS Tumor Gene Analysis Software Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market NGS Tumor Gene Analysis Software Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Region (2018-2029)
Figure 17. Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Region in 2022
Figure 18. North America NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 21. South America NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 23. Global NGS Tumor Gene Analysis Software Revenue Share by Players in 2022
Figure 24. NGS Tumor Gene Analysis Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players NGS Tumor Gene Analysis Software Market Share in 2022
Figure 26. Global Top 6 Players NGS Tumor Gene Analysis Software Market Share in 2022
Figure 27. Global NGS Tumor Gene Analysis Software Consumption Value Share by Type (2018-2023)
Figure 28. Global NGS Tumor Gene Analysis Software Market Share Forecast by Type (2024-2029)
Figure 29. Global NGS Tumor Gene Analysis Software Consumption Value Share by Application (2018-2023)
Figure 30. Global NGS Tumor Gene Analysis Software Market Share Forecast by Application (2024-2029)
Figure 31. North America NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 32. North America NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 33. North America NGS Tumor Gene Analysis Software Consumption Value Market Share by Country (2018-2029)
Figure 34. United States NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe NGS Tumor Gene Analysis Software Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 41. France NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value Market Share by Region (2018-2029)
Figure 48. China NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 51. India NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 54. South America NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 55. South America NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 56. South America NGS Tumor Gene Analysis Software Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa NGS Tumor Gene Analysis Software Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 65. NGS Tumor Gene Analysis Software Market Drivers
Figure 66. NGS Tumor Gene Analysis Software Market Restraints
Figure 67. NGS Tumor Gene Analysis Software Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of NGS Tumor Gene Analysis Software in 2022
Figure 70. Manufacturing Process Analysis of NGS Tumor Gene Analysis Software
Figure 71. NGS Tumor Gene Analysis Software Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. NGS Tumor Gene Analysis Software Picture
Figure 2. Global NGS Tumor Gene Analysis Software Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Type in 2022
Figure 4. Non-Small Cell Lung Cancer
Figure 5. Human 6 Gene Mutations
Figure 6. Human 12 Gene Mutations
Figure 7. Other
Figure 8. Global NGS Tumor Gene Analysis Software Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. NGS Tumor Gene Analysis Software Consumption Value Market Share by Application in 2022
Figure 10. Hospitals and Health Systems Picture
Figure 11. Research Institute Picture
Figure 12. Other Picture
Figure 13. Global NGS Tumor Gene Analysis Software Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global NGS Tumor Gene Analysis Software Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market NGS Tumor Gene Analysis Software Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Region (2018-2029)
Figure 17. Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Region in 2022
Figure 18. North America NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 21. South America NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 23. Global NGS Tumor Gene Analysis Software Revenue Share by Players in 2022
Figure 24. NGS Tumor Gene Analysis Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players NGS Tumor Gene Analysis Software Market Share in 2022
Figure 26. Global Top 6 Players NGS Tumor Gene Analysis Software Market Share in 2022
Figure 27. Global NGS Tumor Gene Analysis Software Consumption Value Share by Type (2018-2023)
Figure 28. Global NGS Tumor Gene Analysis Software Market Share Forecast by Type (2024-2029)
Figure 29. Global NGS Tumor Gene Analysis Software Consumption Value Share by Application (2018-2023)
Figure 30. Global NGS Tumor Gene Analysis Software Market Share Forecast by Application (2024-2029)
Figure 31. North America NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 32. North America NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 33. North America NGS Tumor Gene Analysis Software Consumption Value Market Share by Country (2018-2029)
Figure 34. United States NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe NGS Tumor Gene Analysis Software Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 41. France NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value Market Share by Region (2018-2029)
Figure 48. China NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 51. India NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 54. South America NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 55. South America NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 56. South America NGS Tumor Gene Analysis Software Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa NGS Tumor Gene Analysis Software Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa NGS Tumor Gene Analysis Software Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 65. NGS Tumor Gene Analysis Software Market Drivers
Figure 66. NGS Tumor Gene Analysis Software Market Restraints
Figure 67. NGS Tumor Gene Analysis Software Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of NGS Tumor Gene Analysis Software in 2022
Figure 70. Manufacturing Process Analysis of NGS Tumor Gene Analysis Software
Figure 71. NGS Tumor Gene Analysis Software Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
